My line of research is focused in the design and development of antiviral drugs, specifically directed to adenovirus and BK viruses, for which nowadays there is not a specific drug to treat their infection that is a concern in the transplantation setting, specially at pediatric units.

For this purpose we are working in collaboration with several laboratories in Spain and USA that generate different libraries of small compounds that we screen for their capacity to block infection by these pathogens.

Since we have the expertise and the libraries of small compounds, and  given the urgent necessity to find drugs against the ebolavirus epidemic that we are living in Central Africa, we want to use all we have to collaborate in this matter. We have a BSL-2 setting so obviously we cannot work with the wt virus, so we need a pseudotyped virus to work with.